secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2023-10-16T23:59:59+00:00
Accession:  0001599298-23-000088
Event type: leadership
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 5.02, 3.02, 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit appoints Manmeet Soni as COO; Soni invests $5M, receives 28M options
---------------------------------------------------------------------------

- Soni named COO effective Oct 13, 2023; invested $5M for 2.98M shares at $1.68/share.
- Soni compensation: $600K base, 60% bonus target, 28M options (14M time-vest, 14M performance-vest tied to mkt cap/revenue).
- Dr. Zanganeh granted 23.98M options with same time & performance vesting structure.
- Stockholders approved increase of shares under 2020 Stock Incentive Plan by 70M shares.
- Dave Gancarz, Urte Gayko, Fong Clow, Allen Yang promoted to C-suite roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929823000088/0001599298-23-000088-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929823000088/smmt-20231012.htm
  HTML page:      https://secwatch.observer/filing/0001599298-23-000088

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer